Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-17

FDA Approved: TOPOTECAN HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)

View source ↗

Summary

FDA approved Accord Healthcare's supplemental application for Topotecan hydrochloride, enabling a generic version of the cancer drug to be marketed. Indications…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topotecan hydrochloride (topotecan hydrochloride)

Snippet

SUPPL AP for TOPOTECAN HYDROCHLORIDE (TOPOTECAN HYDROCHLORIDE)